StocksMedium•25 September 2026•
1 min read
Nanexa Shares Surge on €1.17 Billion Novo Nordisk Licensing Deal
Key Facts
1Swedish company Nanexa signed a global licensing deal with Novo Nordisk for injection technology worth up to approximately €1.17 billion.
2Nanexa shares more than doubled in value during early Friday trading following the announcement.
Swedish company Nanexa signed a global licensing deal with Novo Nordisk for injection technology worth up to approximately €1.17 billion. Reuters reported that Nanexa shares more than doubled in value during early Friday trading on September 25, 2026, following the announcement.
The agreement provides Nanexa with significant capital and serves as a major industry validation of its drug-delivery technology by a global pharmaceutical leader. The deal, valued at up to $1.33 billion, triggered a massive price surge for the small-cap firm's shares.